bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Cerevel Therapeutics Inc. logo

    Cerevel Therapeutics Inc.

    CERE | NASDAQ
    Chart Builder DCF Calculator
    $44.96
    +$0.33 (+0.74%)
    At close: Jul 31, 2024, 04:00 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $8.19B
    Enterprise Value
    $7.71B
    Beta
    1.41
    Average Volume
    N/A
    Shares Outstanding (Diluted)
    181.61M
    Shares Change YoY
    15.94%
    Institutional Ownership
    N/A
    Exchange
    N/A
    ISIN
    N/A

    Price Performance

    Price Change 1M
    N/A
    Price Change 3M
    N/A
    Price Change 6M
    N/A
    Price Change YTD
    N/A
    Price Change 1Y
    N/A
    Price Change 3Y
    N/A
    Price Change 5Y
    N/A
    1M CAGR (ann.)
    7.4%
    1Y CAGR (ann.)
    46.7%
    5Y CAGR (ann.)
    N/A
    All-Time CAGR
    39.3%

    Valuation

    PE Ratio
    -16.47
    Forward PE
    N/A
    PEG Ratio
    2.48
    Forward PEG
    0.48
    PS Ratio
    993.39
    Forward PS
    22.30
    PB Ratio
    14.51
    P/FCF Ratio
    -22.09
    P/Adj. FCF Ratio
    -18.26
    P/OCF Ratio
    -21.31
    EV/Sales
    935.42
    EV/EBIT
    -16.73
    EV/EBITDA
    -16.53
    EV/FCF
    -20.80
    Earnings Yield
    -6.1%
    FCF Yield
    -4.5%
    Adj. FCF Yield
    -5.5%

    Financial Health

    Net Cash
    $477.99M
    Total Debt
    $368.3M
    Cash & Short-Term Investments
    $846.29M
    Total Assets
    $1.13B
    Current Ratio
    10.92
    Quick Ratio
    10.92
    Debt / Equity Ratio
    0.71
    Debt / EBITDA
    -0.79
    Debt / FCF
    -0.99
    OCF / Debt
    -1.00
    Interest Coverage
    -42.33
    Altman Z-Score
    6.46
    Piotroski F-Score
    4

    Margins & Profitability

    Gross Profit Margin
    0.0%
    Operating Profit Margin
    -5946.8%
    EBITDA Margin
    0.0%
    Net Profit Margin
    0.0%
    FCF Margin
    -4496.6%
    Adj. FCF Margin
    -5439.5%
    SBC / Revenue
    0.0%
    SBC Impact (per share)
    -21.0%

    Returns

    Return on Assets
    -34.8%
    Return on Equity
    -72.4%
    Return on Invested Capital
    -38.7%
    Return on Capital Employed
    -38.9%
    Return on Tangible Assets
    -34.8%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    150.0%
    Revenue CAGR 5Y
    100.0%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -22.6%
    EPS CAGR 5Y
    -21.5%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -25.2%
    FCF CAGR 5Y
    -31.3%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Hold
    Analyst Count
    16
    EPS Growth Next 3Y
    N/A
    Revenue Growth Next 3Y
    N/A
    Earnings Date
    Aug 6, 2024
    EPS Estimate (next Q)
    -$0.61
    EPS Growth Est (next Q)
    -3.2%
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $33.50
    Price Target Upside
    -25.5%

    Cash Flow

    Operating Cash Flow
    $-367.05M
    Free Cash Flow
    $-370.79M
    Adj. Free Cash Flow
    $-448.54M
    FCF Per Share
    -$2.14
    OCF Per Share
    -$2.11
    OCF/S Ratio
    0.0%

    Income Statement

    Revenue
    $8.25M
    Gross Profit
    $2.4M
    Operating Income
    $-490.37M
    EBITDA
    $-466.76M
    Net Income
    $-460.47M
    EPS (Diluted)
    -$2.73
    Revenue / Employee
    N/A
    Profit / Employee
    N/A
    Employees
    N/A

    © 2026 bestshares.com. All rights reserved.